Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows
An artificial visual sensor with spectral adaptability inspired by the eyes of Pacific salmon
Inspired by the vision systems of Pacific salmons, we designed a spectra-adapted vision sensor based on back-to-back photodiodes. Our vision sensors can collect information in broad spectra and resist the interference of visible light, which improves the accuracy of machine vision systems.
The diverse functions of bacterial purine receptors
Bacteria rely largely on receptors to sense and respond to environmental signals. Different receptor families have evolved that regulate diverse processes like gene expression, metabolism, second messenger homeostasis, chemotaxis or virulence. However, the signals they recognise are mostly unknown.
Behind the Paper: Survey of lived experiences and challenges in hepatitis B management and treatment
Over 250 million individuals are living with hepatitis B worldwide, most remain unaware of their infection. Major barriers to accessing diagnostics, routine management and treatment exist. Values and preferences of people with lived experience are essential to understand barriers.
Neutrons give a hot new way to measure the temperature of electronic components
Our modern world is full of temperature-sensitive electronic devices, and researchers led by Osaka University have developed a faster, highly accurate way to measure the temperatures of such devices using neutrons.
AAV-CXCL9 Combination Immunotherapy: A Promising Strategy in the Treatment of Glioblastoma
Investigators at the University of Florida Brain Tumor Immunotherapy Program developed a novel immunotherapy combining AAV gene therapy and anti-PD-1 immune checkpoint blockade to overcome immune suppression in glioblastoma.
Dysfunctional Protein-Protein Interactome (dfPPI): A Platform for Systems-Level Analysis of PPI Alterations in Disease
Explore Dysfunctional Protein-Protein Interactome (dfPPI): Revealing how aberrant protein interactions drive cancer and neurodegeneration, guiding mechanistic insights and therapeutics innovations.
